Non-Mydriatic Fundus on Phone

Remidio non mydriatic fundus on phone (FOPNM-10) is world’s first and only smartphone based non mydriatic fundus camera with infrared imaging capabilities. The patented optical design (US patent #9398851) and simplicity of a smartphone enables the user to capture reflex free high quality images of the retina at the click of a button.
Remidio non mydriatic fundus on phone (FOPNM-10) is world’s first and only smartphone based non mydriatic fundus camera with infrared imaging capabilities. The patented optical design (US patent #
9398851) and simplicity of a smartphone enables the user to capture reflex free high quality images of
the retina at the click of a button.

Screen anyone, anywhere, anytime

Remidio Fundus On Phone is the world’s first and the only smartphone based, Infrared enabled, high quality disease detection and triaging device to enable universal screening for eye health.

Screen anyone, anywhere, anytime

Remidio Fundus On Phone is the world’s first and the only smartphone based, Infrared enabled, high quality disease detection and triaging device to enable universal screening for eye health.

High-Quality Images

FOPNM-10 uses annular illumination based on Gullstrand principle which is found in the traditional fundus cameras. FOP is the ultimate screening tool for the retina, it uses imaging capabilities of the high-end optics and utility of a smartphone to take high-quality images of the retina.
Validation against Zeiss FF450

High-Quality Images

FOPNM-10 uses annular illumination based on Gullstrand principle which is found in the traditional fundus cameras. FOP is the ultimate screening tool for the retina, it uses imaging capabilities of the high-end optics and utility of a smartphone to take high-quality images of the retina.
Validation against Zeiss FF450

Ease of Use

Artificial Intelligence (AI) Ready

Artificial Intelligence can play a unique role in public health screening for detection of Diabetic Retinopathy. Remidio has validated the EyeArt AI algorithm’s use on Fundus on Phone images in the prestigious publication ‘Eye’ from Springer Nature group.

Artificial Intelligence (AI) Ready

Artificial Intelligence can play a unique role in public health screening for detection of Diabetic Retinopathy. Remidio has validated the EyeArt AI algorithm’s use on Fundus on Phone images in the prestigious publication ‘Eye’ from Springer Nature group.

Ultra-Compact Design

Fundus on phone is based on a two part modular design, one part containing all the optical elements and the other one containing the smartphone. The light weight and sleek form factor makes the device for slitlamp mounted, portable chinrest mounted and handheld usage.

Ultra-Compact Design

Fundus on phone is based on a two part modular design, one part containing all the optical elements and the other one containing the smartphone. The light weight and sleek form factor makes the device for slitlamp mounted, portable chinrest mounted and handheld usage.

Telemedicine ready

FOP is an ideal platform for comprehensive telemedicine enabled eye-wellness screening. The cloud synchronized mobile application of FOPNM-10 enables images to be synced and archived securely in the cloud for remote review and clinical management. Remidio Web Application allows the user to securely login and review images remotely across the globe.

Telemedicine ready

FOP is an ideal platform for comprehensive telemedicine enabled eye-wellness screening. The cloud synchronized mobile application of FOPNM-10 enables images to be synced and archived securely in the cloud for remote review and clinical management. Remidio Web Application allows the user to securely login and review images remotely across the globe.

Secure Intuitive Mobile Application

Remidio Non Mydriatic fundus on phone comes with an application to facilitate capture, report generation and storage of the images. It houses all the post processing features like montage and tools like diabetic retinopathy detection artificial intelligence algorithms. The application is designed to be intuitive, HIPPA and DICOM compliant.

Secure Intuitive Mobile Application

Remidio Non Mydriatic fundus on phone comes with an application to facilitate capture, report generation and storage of the images. It houses all the post processing features like montage and tools like diabetic retinopathy detection artificial intelligence algorithms. The application is designed to be intuitive, HIPPA and DICOM compliant.

Validations and Publications

Remidio FOP is shown to have a clinical specificity of 98% for any DR against Zeiss FF450.
EyeArt Artificial Intelligence Algorithm validated on FOP 99.1% Sensitivity for STDR.
Disclaimer: EyeArt™ has been cleared for sales as a Class IIa medical device by EU and as a Class 2 medical device by Health Canada. In the United States, EyeArt™ is limited by federal law to investigational use only and is not available for sale.

Validations and Publications

Remidio FOP is shown to have a clinical specificity of 98% for any DR against Zeiss FF450.
EyeArt Artificial Intelligence Algorithm validated on FOP 99.1% Sensitivity for STDR.
Disclaimer: EyeArt™ has been cleared for sales as a Class IIa medical device by EU and as a Class 2 medical device by Health Canada. In the United States, EyeArt™ is limited by federal law to investigational use only and is not available for sale.